Hancu Ana, Radulian Gabriela
"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Maedica (Bucur). 2016 Mar;11(1):32-37.
The objective of this analysis was to evaluate the relationship between the changes in the body composition and the changes in the glycemic control as evaluated by glycemia and glycated hemoglobin (HbA1c) and the lipid metabolism parameters in adults with type 2 diabetes.
This was a retrospective cohort study, in which we collected data from the files of 171 patients with type 2 diabetes. The patients were followed for 6 months. Body composition (visceral fat area [VFA; cm], body fat mass [BFM, kg] and percent body fat [PBF; %] was assessed by bioelectric impedance. Delta parameters were calculated as the value of the parameter at month 0 minus the value of the parameter at month 3 or month 6.
All body composition parameters decreased significantly from baseline to month 3 and then to month 6. VFA decreased from 176. 26 cm2 at baseline to 151.21 cm2 at month 3 and to 146.64 cm2 at month 6. PBF decreased from 36.48% to 32.78% at month 3 and to 31.64% at month 6. BFM had a median value of 34.60 kg at baseline and decreased to 29.00 kg at month 3 and 27.95 kg at month 6. At 3 months, delta VAT and delta BFM were correlated with changes in glycemic control and lipid parameters. At 3 months only BFM remained correlated with these parameters.
In the population included in this analysis we showed that changes in VFA and BFM were correlated with changes in glycemic control during the 3-month follow-up period and that changes in BFM were correlated with changes in lipid parameters during the entire follow-up.
本分析的目的是评估2型糖尿病成年患者身体成分变化与血糖控制变化(通过血糖和糖化血红蛋白(HbA1c)评估)以及脂质代谢参数之间的关系。
这是一项回顾性队列研究,我们从171例2型糖尿病患者的病历中收集数据。对患者进行6个月的随访。通过生物电阻抗评估身体成分(内脏脂肪面积[VFA;cm]、体脂质量[BFM,kg]和体脂百分比[PBF;%])。Δ参数计算为第0个月参数值减去第3个月或第6个月参数值。
所有身体成分参数从基线到第3个月,然后到第6个月均显著下降。VFA从基线时的176.26 cm²降至第3个月时的151.21 cm²,第6个月时降至146.64 cm²。PBF从基线时的36.48%降至第3个月时的32.78%,第6个月时降至31.64%。BFM基线中位数为34.60 kg,第3个月降至29.00 kg,第6个月降至27.95 kg。在3个月时,Δ内脏脂肪量和ΔBFM与血糖控制和脂质参数变化相关。仅在3个月时,BFM仍与这些参数相关。
在本分析纳入的人群中,我们发现VFA和BFM的变化在3个月随访期内与血糖控制变化相关,且BFM的变化在整个随访期内与脂质参数变化相关。